In Focus: recent therapies in renal cell carcinoma
In our latest In Focus, Prof Brian Rini (Vanderbilt-Ingram Cancer Center, TN, USA) discusses the treatment landscape for people living with renal cell carcinoma (RCC), as well as the current challenges and limitations of current therapies and how he hopes the treatment landscape will evolve over the next 5 years.
In this article, Prof Brian Rini discusses recent therapies in RCC, as well as predictions for the future of the treatment landscape.
Our recent In Focus has focused on recent therapies for RCC. This infographic summarizes the key points, including available therapies and how the field will evolve.